	A logNII-based model for predicting pathological complete response following neoadjuvant therapy in esophageal squamous cell carcinoma: a retrospective single-center study. World J Surg Oncol Zhang M, Huang J, Wang C, Yang B, Lu T. PMID: 42218485 [PubMed - as supplied by publisher]
	Cytoreductive radical prostatectomy in patients with high-volume metastatic prostate cancer achieving deep biochemical response to contemporary systemic therapy: a multicentre, prospective cohort study. BMC Med Huang C, Guo H, Gao W, Huang M, Ji G, Rui R, He S, Yu Y, Zhang N, Tian Y, Niu Y, Li X, Zhou L. PMID: 42218463 [PubMed - as supplied by publisher]
	Development and external validation of multiple machine learning-based models for breast cancer-specific survival prediction in postoperative patients with invasive breast cancer: a study based on the SEER database and an external cohort. BMC Cancer Liu S, Liu J, Li D, Mo Q. PMID: 42218459 [PubMed - as supplied by publisher]
	Rewiring the immune circuit: programming tumor-draining lymph node immunity with nanotechnology. J Nanobiotechnology Chen X, Zou M, Li N, Zhou Z, Xu R, Feng W, Guo Z, Zhao X, Cui L. PMID: 42218454 [PubMed - as supplied by publisher]
	Extracellular vesicle and particle biomarkers in cancer: a machine learning blueprint for liquid biopsy. J Nanobiotechnology Yu J, Xu G, Li Y, Huang M, Yang L, Peng X. PMID: 42218435 [PubMed - as supplied by publisher]
	Exploring the functional role of palmitoylation genes in clear cell renal cell carcinoma and their impact on tumor microenvironment. BMC Genom Data Li J, Chang H, Xu H, Bai Y, Tang W. PMID: 42218414 [PubMed - as supplied by publisher]
	Nipple aspirate fluid as aÂ proximal breast liquid biopsy platform: advancing precision risk management in breast cancer. Clin Proteomics Guo S, Liu J, Zheng H, Wu X. PMID: 42218386 [PubMed - as supplied by publisher]
	Deep learning-based cervical cancer T-staging using MRI: multi-structure segmentation and classification. BMC Med Imaging Xu S, Zou Y, Wu Z, Xu Z, Wang R, Hou W, Wang Y, Wu Y. PMID: 42218381 [PubMed - as supplied by publisher]
	Real-World Comparative Effectiveness and Safety of Immune Checkpoint Inhibitors in Advanced Renal Cell Carcinoma: A Systematic Review. Target Oncol Yiu CH, Leung GYY, Lee IC, Lu CY. PMID: 42218357 [PubMed - as supplied by publisher]
	Primary site- and metastasis-directed therapies in patients with metastatic prostate cancer: A narrative review. Int J Clin Oncol Goto T, Mizuno K, Sumiyoshi T, Kita Y, Masui K, Ogata T, Aizawa R, Sawada A, Saito R, Mizowaki T, Kobayashi T. PMID: 42218356 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Prognostic Value of Circulating Exosomal DNA in Esophageal Squamous Cell Carcinoma: A Prospective Cohort Study. Ann Surg Oncol Nakai T, Kitahata Y, Hiraki H, Nakamura Y, Motobayashi H, Takemoto N, Hyo T, Sato M, Ojima T, Hayata K, Goda T, Kitadani J, Tominaga S, Hayami S, Miyamoto A, Yamaue H, Iwaya T, Nishizuka S, Kawai M. PMID: 42218348 [PubMed - as supplied by publisher]
	Exploratory Comparison of Meld, Meld-Na, and Meld 3.0 Scores for Prognostic Assessment at Diagnosis in Hepatocellular Carcinoma Using Machine Learning Approaches. Dig Dis Sci Martínez-Blanco P, Suárez M, Mateo J, Gil-Rojas S, Martínez-García N, Blasco P, Torralba M, Torres AM. PMID: 42218308 [PubMed - as supplied by publisher]
	Efficacy of chemoradiotherapy in pediatric H3K27M-mutant diffuse intrinsic pontine glioma: a study based on single-center and SEER data. J Neurooncol Wang D, Liu X, Wang J, Zhang B, Zhai S, Xu J, Wang L, Zheng Y, Wei W, Zhou Y. PMID: 42218248 [PubMed - indexed for MEDLINE]
	Multi-ancestry transcriptome-wide association studies uncover insights into breast cancer genetics and biology. Nat Commun Ping J, Jia G, Cai Q, Guo X, Wang J, Tao R, Li B, Bauer JA, Xie Y, Ambs S, Barnard ME, Chen Y, Choi JY, Gao YT, Garcia-Closas M, Gu J, Hu JJ, Iwasaki M, John EM, Kweon SS, Li CI, Matsuda K, Matsuo K, Nathanson KL, Nemesure B, Olopade OI, Pal T, Park SK, Park B, Press MF, Sanderson M, Sandler DP, Yao S, Zheng Y, Ahearn T, Brewster AM, Falusi A, Hennis AJM, Ito H, Kubo M, Lee ES, Makumbi T, Mapoko BSE, Noh DY, O'Brien KM, Ojengbede O, Olshan AF, Park MH, Reid S, Yamaji T, Zirpoli G, Butler EN, Huang M, Low SK, Obafunwa J, Weinberg CR, Zhang H, Zhao H, Ambrosone CB, Cote ML, Huo D, Haiman CA, Kang D, Palmer JR, Troester MA, Shu XO, Long J, Zheng W. PMID: 42218145 [PubMed - as supplied by publisher]
	Radionuclide Combination Strategies in Prostate Cancer: Insights from the AlphaBet Trial. Eur Urol Focus Kostos L, Buteau JP, Azad AA, Hofman MS. PMID: 42218070 [PubMed - as supplied by publisher]
	New Paradigms in Theranostics of Prostate Cancer: The Rise of Î±-Emitters and Next-generation Targets. Eur Urol Focus Deandreis D, Deutsch E. PMID: 42218069 [PubMed - as supplied by publisher]
	Genetically predicted gut bacteria, circulating bacteria-associated metabolites and liver cancer: A Mendelian randomisation study. Dig Liver Dis Daniel N, Papadimitriou N, Chatziioannou AC, Jenab M, Mayén AL, Keski-Rahkonen P, Fedirko V, Hassan MM, Hughes DJ. PMID: 42218054 [PubMed - as supplied by publisher]
	The role of Ca(2+) channels in oral squamous cell carcinoma development. J Oral Biosci Hasegawa K, Fujii S, Kiyoshima T. PMID: 42218017 [PubMed - indexed for MEDLINE]
	Cuproptosis: An emerging strategy for nanomaterial for the treatment of cancer. Colloids Surf B Biointerfaces Che X, Cao S, Shao Q, Duan W, Cai Y, Yang Z. PMID: 42217853 [PubMed - as supplied by publisher]
	Unravelling the mystery of hypoxia-induced miRNAs in breast cancer: A molecular cross-talk driving tumour progression and therapy resistance. Mol Aspects Med Sharma N, Yadav V, Sinha S, Kumari L, Sethi A, Marcus S, Pratap Singh M, Kaur S, Garg N, Pathak A, Vellingir B, Kumar S. PMID: 42217842 [PubMed - as supplied by publisher]

Articles 1 - 20 / 1939828

Page 1 of 96992



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy